{"id":1029,"date":"2024-03-07T09:51:04","date_gmt":"2024-03-07T09:51:04","guid":{"rendered":"https:\/\/www.asklepios-advisors.com\/?p=1029"},"modified":"2024-03-11T12:06:59","modified_gmt":"2024-03-11T12:06:59","slug":"cousin-surgery-acquires-planttec-medical","status":"publish","type":"post","link":"https:\/\/www.asklepios-advisors.com\/index.php\/2024\/03\/07\/cousin-surgery-acquires-planttec-medical\/","title":{"rendered":"Cousin Surgery Acquires PlantTec Medical"},"content":{"rendered":"\n

L\u00fcneburg, Germany and Wervicq-Sud, France – April 27th, 2023<\/em><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Cousin Surgery, a leading implantable medical device company, has successfully completed
the acquisition of PlantTec Medical, a prominent German surgical medical device firm
specializing in hemostatic and adhesion prevention solutions.
\u00a0
PlantTec Medical is the first company in the world to CE-certify a plant-based product for
surgery that not only effectively stops surgical bleeding, but also substantially prevents
postoperative tissue adhesions. The polysaccharide-based product 4DRYFIELD\u00ae has been
used more than 350,000 times in surgical procedures. Their innovative solutions are currently
sold in over 30 countries in hospitals and clinics worldwide through distributors and through
an established direct salesforce in Germany.
\u00a0
Cousin Surgery is a French group specialized in implantable medical devices with a
longstanding industrial expertise. Today, the company is a recognized as a specialist in
implantable textiles and their application to spine and visceral surgery.
Private equity healthcare specialist fund of Turenne Group, Capital Sant\u00e9 2, with his co-
investors – Nord Capital Investissement, S\u00e9lection & Opportunit\u00e9s (Turenne Group), Dalle &
Associ\u00e9s and Altur Investissement \u2013 and the Management have funded Cousin Surgery in its
acquisition of PlantTec Medical.
\u00a0
The acquisition of PlantTec Medical will create immediate cross-selling opportunities and
drive R&D innovation for Cousin Surgery. \u00ab\u00a0PlantTec Medical provides us with an exceptional
team possessing deep expertise in delivering surgical medical device solutions for patients
especially in Germany.\u00a0\u00bb say Cousin Surgery’s CEOs, Fran\u00e7ois Tortel and Fran\u00e7ois Henin. \u00ab\u00a0This
acquisition significantly expands our high-quality portfolio, addressing the needs of
physicians and patients in vascular, gynecological, orthopedic, and general surgery. It’s a
perfect fit for us.\u00a0\u00bb
\u00a0
In a strategic move, PlantTec Medical’s founders and CEOs, Ellen and Joachim Laas, will not
only remain in the company but also invest in the group. \u00ab\u00a0This deal propels 4DRYFIELD\u00ae and
PlantTec Medical to the next level of global growth,\u00a0\u00bb they state.
\u00a0
Raquel Pires and Beno\u00eet Pastour, Executive Director and Managing Director at Turenne
Capital, expressed their pride in the strategic transaction with PlantTec Medical. \u00ab\u00a0We’ve
closely monitored the company’s growth over the past years and recognize its full potential,
driven by a talented management team that we are thrilled to work with now.\u00a0\u00bb
\u00a0
Edouard Nuttin, CEO, and Jean-Bastien Bloch, Investment Manager at Roquette Ventures,
commented: \u00ab\u00a0We’re proud to have supported PlantTec Medical and its management team in
their remarkable growth since its inception. This journey, aligned with Roquette Venture\u2019s
approach, has resulted in significant geographical expansion and impressive commercial
traction. We’re pleased to see PlantTec Medical join an ambitious new project and are <\/p>\n\n\n\n

excited about the opportunities and synergies with Cousin Surgery. We wish Ellen, Joachim
Laas, and their team all the success they deserve in this new venture.\u00a0\u00bb
Dr. Edouard Gobitz, Managing Partner Asklepios Advisors, Healthcare Investment Bank
added: \u201cOur firm is proud to have supported Roquette Ventures & PlantTec Medical
founders. This transaction demonstrates Asklepios Advisors commitment to supporting
healthcare clients over the long term in all stages of their development.\u201d
Asklepios Advisors served as Roquette Group and PlantTec Medical’s exclusive financial
advisor, with Osborne Clarke as the legal advisor for the seller.
Kroll (finance, tax due diligence), McDermott Will Emery (legal, social due diligence) and
Lamartine Conseil (legal advisor for financing) supported the buyer. The existing pool of
banks, Cr\u00e9dit Agricole Mutuel Nord de France, CIC Nord Ouest and Caisse d\u2019Epargne Hauts de
France, contributed to the financing of the acquisition.<\/p>\n","protected":false},"excerpt":{"rendered":"

L\u00fcneburg, Germany and Wervicq-Sud, France – April 27th, 2023 Cousin Surgery, a leading implantable medical device company, has successfully completedthe acquisition of PlantTec Medical, a prominent German surgical medical device firmspecializing in hemostatic and adhesion prevention solutions.\u00a0PlantTec Medical is the first company in the world to CE-certify a plant-based product forsurgery that not only effectively […]<\/p>\n","protected":false},"author":1,"featured_media":1025,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/posts\/1029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/comments?post=1029"}],"version-history":[{"count":3,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/posts\/1029\/revisions"}],"predecessor-version":[{"id":1034,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/posts\/1029\/revisions\/1034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/media\/1025"}],"wp:attachment":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/media?parent=1029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/categories?post=1029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/tags?post=1029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}